DE69721314D1 - Hormonzusammensetzung welche ein östrogenes mittel und ein progestatives mittel enthält - Google Patents

Hormonzusammensetzung welche ein östrogenes mittel und ein progestatives mittel enthält

Info

Publication number: DE69721314D1
Authority: DE; Germany
Prior art keywords: agent; progestative; estrogen; hormone composition; hormone
Prior art date: 1996-10-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69721314T

Other languages

English (en)

Other versions

DE69721314T2 (de

Inventor

Michel Lanquetin

Jacques Paris

Jean-Louis Thomas

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Laboratoire Theramex SAM

Original Assignee

Laboratoire Theramex SAM

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-08

Filing date

1997-10-08

Publication date

2003-05-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9496456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69721314(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-10-08 Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM

2003-05-28 Publication of DE69721314D1 publication Critical patent/DE69721314D1/de

2004-02-12 Application granted granted Critical

2004-02-12 Publication of DE69721314T2 publication Critical patent/DE69721314T2/de

2017-10-09 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Orthopedics, Nursing, And Contraception (AREA)

DE69721314T 1996-10-08 1997-10-08 Hormonzusammensetzung welche ein östrogenes mittel und ein progestatives mittel enthält Expired - Lifetime DE69721314T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9612239		1996-10-08
FR9612239A FR2754179B1 (fr)	1996-10-08	1996-10-08	Nouvelle composition hormononale et son utilisation
PCT/FR1997/001792 WO1998015279A1 (fr)	1996-10-08	1997-10-08	Composition hormonale constituee d'un compose estrogene et d'un compose progestatif

Publications (2)

Publication Number	Publication Date
DE69721314D1 true DE69721314D1 (de)	2003-05-28
DE69721314T2 DE69721314T2 (de)	2004-02-12

Family

ID=9496456

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DE69737373T Expired - Lifetime DE69737373T2 (de)	1996-10-08	1997-10-08	Östroprogestatives Antikonzeptionsmittel
DE69721314T Expired - Lifetime DE69721314T2 (de)	1996-10-08	1997-10-08	Hormonzusammensetzung welche ein östrogenes mittel und ein progestatives mittel enthält
DE201212000010 Pending DE122012000010I1 (de)	1996-10-08	2012-01-23	Ostroprogestatives Antikonzeptionsmittel.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DE69737373T Expired - Lifetime DE69737373T2 (de)	1996-10-08	1997-10-08	Östroprogestatives Antikonzeptionsmittel

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE201212000010 Pending DE122012000010I1 (de)	1996-10-08	2012-01-23	Ostroprogestatives Antikonzeptionsmittel.

Country Status (38)

Country	Link
US (4)	US6831073B1 (de)
EP (2)	EP1334725B1 (de)
JP (1)	JP4883542B2 (de)
KR (2)	KR100782638B1 (de)
CN (3)	CN101229173A (de)
AP (1)	AP1171A (de)
AR (2)	AR009113A1 (de)
AT (2)	ATE353652T1 (de)
AU (1)	AU745571B2 (de)
BR (1)	BR9712274A (de)
CA (1)	CA2268358C (de)
CL (1)	CL2011000017A1 (de)
CZ (1)	CZ298402B6 (de)
DE (3)	DE69737373T2 (de)
DK (2)	DK0956022T3 (de)
DZ (1)	DZ2327A1 (de)
ES (2)	ES2198006T3 (de)
FR (2)	FR2754179B1 (de)
HK (1)	HK1210708A1 (de)
HU (2)	HU227450B1 (de)
ID (1)	ID21569A (de)
IL (1)	IL129194A (de)
LU (1)	LU91932I2 (de)
MA (1)	MA24370A1 (de)
MY (1)	MY128482A (de)
NO (3)	NO324357B1 (de)
NZ (1)	NZ334876A (de)
OA (1)	OA11033A (de)
PL (1)	PL192979B1 (de)
PT (2)	PT1334725E (de)
RU (1)	RU2274450C2 (de)
SK (2)	SK285056B6 (de)
TN (1)	TNSN97164A1 (de)
TR (1)	TR199900764T2 (de)
TW (1)	TW491704B (de)
WO (1)	WO1998015279A1 (de)
YU (1)	YU18099A (de)
ZA (1)	ZA979011B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4344462C2 (de)	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
DE19549264A1 (de) *	1995-12-23	1997-06-26	Schering Ag	Verfahren und Kit zur Kontrazeption
FR2754179B1 (fr)	1996-10-08	1998-12-24	Theramex	Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) *	1999-10-25	2001-05-03	Laboratoire Theramex	Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
WO2001030356A1 (fr) *	1999-10-25	2001-05-03	Laboratoire Theramex	Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) *	2000-09-15	2003-03-07	Theramex	Nouvelles compositions estro-progestatives topiques a effet systemique
FR2823976A1 (fr) *	2001-04-25	2002-10-31	Theramex	Nouvelle composition hormonale et son utilisation
UY29185A1 (es) *	2004-11-02	2006-05-31	Schering Ag	Formas de dosificación oral sólidas que contienen una dosis baja de estradiol
PE20081895A1 (es)	2007-03-26	2009-01-26	Theramex	Regimen anticonceptivo oral
RU2332219C1 (ru) *	2007-03-30	2008-08-27	Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА)	Средство для модуляции плотности н2-гистаминовых рецепторов сердца при менопаузе
US20080293683A1 (en) *	2007-05-24	2008-11-27	University Of Kansas Medical Center	Hormone Replacement Therapy
AR066166A1 (es) *	2007-09-21	2009-07-29	Organon Nv	Sistema de suministro de droga
US10413504B2 (en)	2013-12-11	2019-09-17	Merck Sharp & Dohme Corp.	Intravaginal ring drug delivery system
EP3079659B1 (de)	2013-12-11	2020-10-28	Merck Sharp & Dohme B.V.	Arzneimittelliefersystem zur verabreichung von virenbekämpfungsmitteln
US20230398127A1 (en) *	2020-10-16	2023-12-14	Theramex HQ UK Limited	Use of combined oral contraceptives containing nomegestrol acetate and estradiol
KR102744791B1 (ko)	2022-07-05	2024-12-19	주식회사 이음정보	소멸특허 관리 및 특허거래 시스템

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3271392A (en) *	1965-09-14	1966-09-06	American Home Prod	17alpha-[3'-furyl]-estrogens
US4390531A (en)	1981-08-10	1983-06-28	Syntex Pharmaceuticals International Ltd.	Method of contraception using peak progestogen dosage
US4921843A (en)	1988-10-20	1990-05-01	Pasquale Samuel A	Contraception system and method
US4826831A (en)	1983-08-05	1989-05-02	Pre Jay Holdings Limited	Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4628051A (en)	1983-09-26	1986-12-09	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
JPS61243059A (ja)	1985-04-19	1986-10-29	Konishi Kagaku Kogyo Kk	高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
US5208225A (en)	1986-02-27	1993-05-04	Warner-Lambert Company	Compositions containing fixed combinations
ZA87332B (en)	1986-02-27	1987-08-26	Warner Lambert Co	Compositions containing fixed combinations
US5145682A (en) *	1986-05-30	1992-09-08	Rutgers, The State University Of New Jersey	Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
DK174724B1 (da)	1986-07-15	2003-10-06	Wyeth Corp	Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
CA1332227C (en)	1987-09-24	1994-10-04	Robert F. Casper	Oral contraceptive formulation
US5276022A (en)	1987-09-24	1994-01-04	Jencap Research Ltd.	Hormone preparation and method
FI101601B1 (fi) *	1987-09-24	1998-07-31	Jencap Research Ltd	Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmisteen valmistusmenetelmässä
US5108995A (en)	1987-09-24	1992-04-28	Jencap Research Ltd.	Hormone preparation and method
US5256421A (en)	1987-09-24	1993-10-26	Jencap Research Ltd.	Hormone preparation and method
HUT52382A (en)	1988-03-14	1990-07-28	Sandoz Ag	Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en)	1990-12-13	1997-02-12	Akzo Nv	Low estrogen oral contraceptives
IE62665B1 (en)	1990-12-17	1995-02-22	Akzo Nv	Contraceptive regimen
FR2695826B1 (fr) *	1992-09-21	1995-01-06	Theramex	Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US6150343A (en)	1993-06-30	2000-11-21	University Of Pittsburgh	Camptothecin analogs and methods of preparation thereof
US5554601A (en) *	1993-11-05	1996-09-10	University Of Florida	Methods for neuroprotection
DE4344462C2 (de) *	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
US5552394A (en) *	1994-07-22	1996-09-03	The Medical College Of Hampton Roads	Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en)	1994-09-22	2003-09-02	Board Of Regents, The University Of Texas System	Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv)	1994-10-06	1994-10-06	Astra Ab	Pharmaceutical composition containing derivattves of sex hormones
FR2737411B1 (fr) *	1995-08-01	1997-10-17	Theramex	Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE19540253C2 (de)	1995-10-28	1998-06-04	Jenapharm Gmbh	Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de)	1995-12-23	1997-06-26	Schering Ag	Verfahren und Kit zur Kontrazeption
AU2926897A (en)	1996-05-08	1997-11-26	American Home Products Corporation	Oral contraceptive
WO1997041868A1 (en)	1996-05-08	1997-11-13	American Home Products Corporation	Oral contraceptive
WO1997041869A1 (en)	1996-05-08	1997-11-13	American Home Products Corporation	Oral contraceptive
AU2926997A (en)	1996-05-08	1997-11-26	American Home Products Corporation	Oral contraceptive
AU2746097A (en)	1996-05-08	1997-11-26	American Home Products Corporation	Oral contraceptive
AU3888697A (en)	1996-07-26	1998-02-20	American Home Products Corporation	Progestin/estrogen oral contraceptive
WO1998004265A1 (en)	1996-07-26	1998-02-05	American Home Products Corporation	Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen
AU3961697A (en)	1996-07-26	1998-02-20	American Home Products Corporation	Oral contraceptive
US5888543A (en) *	1996-07-26	1999-03-30	American Home Products Corporation	Oral contraceptives
DK0917466T3 (da)	1996-07-26	2004-12-20	Wyeth Corp	Oralt antikonceptionsmiddel
AU3888597A (en)	1996-07-26	1998-02-20	American Home Products Corporation	Oral contraceptive
FR2754179B1 (fr)	1996-10-08	1998-12-24	Theramex	Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr)	1999-10-25	2001-05-03	Laboratoire Theramex	Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
DE19705229C2 (de)	1997-02-12	1999-04-15	Hesch Rolf Dieter Prof Dr Med	Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en)	1997-06-23	1999-04-27	Medical College Of Hampton Roads	Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
ATE279198T1 (de)	1997-08-27	2004-10-15	Ortho Mcneil Pharm Inc	Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
DE19739916C2 (de) *	1997-09-11	2001-09-13	Hesch Rolf Dieter	Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
EP1011681A1 (de)	1997-09-12	2000-06-28	American Home Products Corporation	Orale kontrazeptive zubereitung enthaltend eine erste phase enthaltende eine kombination von gestagen/estrogen und eine zweite phase enthaltend gestagen
WO2001030356A1 (fr)	1999-10-25	2001-05-03	Laboratoire Theramex	Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

1996
- 1996-10-08 FR FR9612239A patent/FR2754179B1/fr not_active Expired - Fee Related
1997
- 1997-10-07 TN TNTNSN97164A patent/TNSN97164A1/fr unknown
- 1997-10-08 ID IDW990211A patent/ID21569A/id unknown
- 1997-10-08 CA CA2268358A patent/CA2268358C/fr not_active Expired - Lifetime
- 1997-10-08 RU RU2003107072/15A patent/RU2274450C2/ru active
- 1997-10-08 TR TR1999/00764T patent/TR199900764T2/xx unknown
- 1997-10-08 DZ DZ970177A patent/DZ2327A1/xx active
- 1997-10-08 DE DE69737373T patent/DE69737373T2/de not_active Expired - Lifetime
- 1997-10-08 PL PL332610A patent/PL192979B1/pl unknown
- 1997-10-08 NZ NZ334876A patent/NZ334876A/xx not_active IP Right Cessation
- 1997-10-08 MA MA24828A patent/MA24370A1/fr unknown
- 1997-10-08 MY MYPI97004717A patent/MY128482A/en unknown
- 1997-10-08 PT PT03008979T patent/PT1334725E/pt unknown
- 1997-10-08 CN CNA2007101694575A patent/CN101229173A/zh active Pending
- 1997-10-08 AT AT03008979T patent/ATE353652T1/de active
- 1997-10-08 DK DK97944940T patent/DK0956022T3/da active
- 1997-10-08 SK SK438-99A patent/SK285056B6/sk not_active IP Right Cessation
- 1997-10-08 ES ES97944940T patent/ES2198006T3/es not_active Expired - Lifetime
- 1997-10-08 AT AT97944940T patent/ATE238057T1/de active
- 1997-10-08 AU AU46273/97A patent/AU745571B2/en not_active Expired
- 1997-10-08 CN CN201510024865.6A patent/CN104706641A/zh active Pending
- 1997-10-08 CZ CZ0112099A patent/CZ298402B6/cs not_active IP Right Cessation
- 1997-10-08 YU YU18099A patent/YU18099A/sh unknown
- 1997-10-08 BR BR9712274-2A patent/BR9712274A/pt not_active Application Discontinuation
- 1997-10-08 ZA ZA9709011A patent/ZA979011B/xx unknown
- 1997-10-08 CN CN97180380A patent/CN1239893A/zh active Pending
- 1997-10-08 DE DE69721314T patent/DE69721314T2/de not_active Expired - Lifetime
- 1997-10-08 WO PCT/FR1997/001792 patent/WO1998015279A1/fr not_active Ceased
- 1997-10-08 PT PT97944940T patent/PT956022E/pt unknown
- 1997-10-08 US US09/284,147 patent/US6831073B1/en not_active Expired - Lifetime
- 1997-10-08 AR ARP970104638A patent/AR009113A1/es not_active Application Discontinuation
- 1997-10-08 HU HU9904508A patent/HU227450B1/hu active Protection Beyond IP Right Term
- 1997-10-08 EP EP03008979A patent/EP1334725B1/de not_active Expired - Lifetime
- 1997-10-08 IL IL12919497A patent/IL129194A/xx not_active IP Right Cessation
- 1997-10-08 SK SK5098-2005A patent/SK285455B6/sk active Protection Beyond IP Right Term
- 1997-10-08 JP JP51726398A patent/JP4883542B2/ja not_active Expired - Lifetime
- 1997-10-08 ES ES03008979T patent/ES2282539T3/es not_active Expired - Lifetime
- 1997-10-08 EP EP97944940A patent/EP0956022B1/de not_active Expired - Lifetime
- 1997-10-08 KR KR1020067013702A patent/KR100782638B1/ko not_active Expired - Lifetime
- 1997-10-08 AP APAP/P/1999/001500A patent/AP1171A/en active
- 1997-10-08 KR KR1019990703032A patent/KR20000048981A/ko not_active Withdrawn
- 1997-10-08 DK DK03008979T patent/DK1334725T3/da active
- 1997-10-15 TW TW086115281A patent/TW491704B/zh not_active IP Right Cessation
1999
- 1999-03-31 NO NO19991593A patent/NO324357B1/no not_active IP Right Cessation
- 1999-04-08 OA OA9900078A patent/OA11033A/fr unknown
- 1999-10-25 US US09/423,108 patent/US6906049B1/en not_active Expired - Lifetime
2004
- 2004-01-08 US US10/753,073 patent/US20040220163A1/en not_active Abandoned
2007
- 2007-01-03 US US11/649,672 patent/US7749987B2/en not_active Expired - Fee Related
2009
- 2009-10-26 AR ARP090104109A patent/AR073972A2/es not_active Application Discontinuation
2011
- 2011-01-06 CL CL2011000017A patent/CL2011000017A1/es unknown
2012
- 2012-01-13 LU LU91932C patent/LU91932I2/fr unknown
- 2012-01-19 FR FR12C0005C patent/FR12C0005I2/fr active Active
- 2012-01-23 DE DE201212000010 patent/DE122012000010I1/de active Pending
- 2012-01-24 NO NO2012002C patent/NO2012002I2/no not_active IP Right Cessation
- 2012-01-26 HU HUS1200002C patent/HUS1200002I1/hu unknown
2015
- 2015-11-24 HK HK15111561.9A patent/HK1210708A1/xx unknown
2017
- 2017-08-08 NO NO2017043C patent/NO2017043I2/no unknown

Also Published As

Publication number	Publication date
KR100782638B1 (ko)	2007-12-06
ES2198006T3 (es)	2004-01-16
YU18099A (sh)	2002-03-18
DZ2327A1 (fr)	2002-12-28
CL2011000017A1 (es)	2011-06-24
NO2017043I1 (no)	2017-08-08
AR009113A1 (es)	2000-03-08
EP0956022A1 (de)	1999-11-17
FR12C0005I2 (fr)	2016-06-24
EP1334725A3 (de)	2004-01-21
CN104706641A (zh)	2015-06-17
CA2268358C (fr)	2010-04-20
ID21569A (id)	1999-06-24
DE69737373D1 (de)	2007-03-29
DK1334725T3 (da)	2007-06-11
LU91932I9 (de)	2018-12-27
HK1210708A1 (en)	2016-05-06
PT1334725E (pt)	2007-05-31
ZA979011B (en)	1998-06-03
CA2268358A1 (fr)	1998-04-16
KR20000048981A (ko)	2000-07-25
HU227450B1 (en)	2011-06-28
HUP9904508A2 (hu)	2000-06-28
NO2017043I2 (no)	2019-01-25
AU745571B2 (en)	2002-03-21
SK285056B6 (sk)	2006-05-04
DE122012000010I1 (de)	2012-04-19
EP0956022B1 (de)	2003-04-23
FR12C0005I1 (fr)	2012-02-24
LU91932I2 (fr)	2012-03-13
AR073972A2 (es)	2010-12-15
IL129194A (en)	2003-06-24
AP1171A (en)	2003-06-30
PT956022E (pt)	2003-07-31
NO991593L (no)	1999-06-07
FR2754179A1 (fr)	1998-04-10
NO324357B1 (no)	2007-10-01
ATE238057T1 (de)	2003-05-15
JP4883542B2 (ja)	2012-02-22
ATE353652T1 (de)	2007-03-15
PL192979B1 (pl)	2006-12-29
US6906049B1 (en)	2005-06-14
SK285455B6 (sk)	2007-01-04
IL129194A0 (en)	2000-02-17
FR2754179B1 (fr)	1998-12-24
CN101229173A (zh)	2008-07-30
CN1239893A (zh)	1999-12-29
WO1998015279A1 (fr)	1998-04-16
HUP9904508A3 (en)	2001-01-29
EP1334725A2 (de)	2003-08-13
KR20060084864A (ko)	2006-07-25
US20040220163A1 (en)	2004-11-04
CZ298402B6 (cs)	2007-09-19
NZ334876A (en)	2001-06-29
MA24370A1 (fr)	1998-07-01
US6831073B1 (en)	2004-12-14
SK43899A3 (en)	1999-12-10
NO2012002I1 (no)	2012-01-24
TW491704B (en)	2002-06-21
DE69721314T2 (de)	2004-02-12
DK0956022T3 (da)	2003-08-04
TR199900764T2 (xx)	1999-07-21
MY128482A (en)	2007-02-28
AP9901500A0 (en)	1999-06-30
JP2002509524A (ja)	2002-03-26
US7749987B2 (en)	2010-07-06
RU2274450C2 (ru)	2006-04-20
DE69737373T2 (de)	2007-06-21
BR9712274A (pt)	1999-08-31
HUS1200002I1 (hu)	2016-08-29
AU4627397A (en)	1998-05-05
NO2012002I2 (no)	2013-04-02
OA11033A (fr)	2003-03-06
TNSN97164A1 (fr)	1999-12-31
US20070281912A1 (en)	2007-12-06
ES2282539T3 (es)	2007-10-16
EP1334725B1 (de)	2007-02-14
PL332610A1 (en)	1999-09-27
NO991593D0 (no)	1999-03-31
CZ9901120A3 (cs)	2000-11-15

Publication	Publication Date	Title
DE69721314D1 (de)	2003-05-28	Hormonzusammensetzung welche ein östrogenes mittel und ein progestatives mittel enthält
NL1005424A1 (nl)	1997-09-05	Alkylfenylbisacylfosfineoxiden en fotoinitiatormengsels.
DE69812433D1 (de)	2003-04-24	Anti-estrogene steroide, pharmazeutische zusammensetzungen und verwendungen davon
PT881906E (pt)	2004-10-29	Composicao farmaceutica para a imunomodelacao baseada em peptideos e adjuvantes
HUP0001020A3 (en)	2001-10-29	Stanol composition and the use thereof
GB9927637D0 (en)	2000-01-19	Cross-linker for photoresist and photoresist composition comprising the same
ZA978889B (en)	1998-04-08	New combination of steroids.
AU1121799A (en)	1999-05-24	Emulsion composition monitor
EP0930540A4 (de)	1999-12-29	Fotpempfindliche zusammensetzung und deren verwendung
AU5252698A (en)	1998-06-03	Therapeutic compositions and methods and diagnostic assays for type ii diabetes involving hnf-1
DE69724367D1 (de)	2003-10-02	Polyarylensulfid und zusammensetzung
BR9508110A (pt)	1997-08-12	Derivado de triterpeno e composição médica
FR2779642B1 (fr)	2002-05-17	Composition cosmetique comprenant au moins un polyester sulfonique ramifie et au moins un agent de conditionnement
BR9509688A (pt)	1997-09-30	Composto e composição farmacêutica
PT1140110E (pt)	2003-11-28	Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas
IL140742A0 (en)	2002-02-10	Raloxifene and pharmaceutical composition comprising the same
HUP0100210A3 (en)	2001-12-28	Novel 11betha-substituted 19-nor steroids, preparation thereof, intermediates and pharmaceutical compositions containing them
GB9722691D0 (en)	1997-12-24	Emulsion composition
GB9606579D0 (en)	1996-06-05	Pharmaceutical composition and methods for the manufacture thereof
IL116504A0 (en)	1996-03-31	14, 17-C2-bridged steroids and pharmaceutical compositions containing the same
DE69809796D1 (de)	2003-01-09	Rf-dreiwegkombinierer/-verteiler
PL328564A1 (en)	1999-02-01	Ferrite-calcium flux, charge mix for obtaining same and application thereof
IL126623A0 (en)	1999-08-17	Pharmaceutical compositions and kits for dhea combined therapy
EP0754701A4 (de)	1996-12-02	Neue progesteronverbindung und ihre verwendung
HUP9901474A3 (en)	2000-02-28	Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy

Legal Events

Date	Code	Title	Description
2006-05-18	8364	No opposition during term of opposition